Maximizing chances to succeed in taking break-through therapies from phase I to the patient. We broadly leverage our expertise in medical imaging, AI based analytics, DYNAMIKA, the cloud platform and risk sharing business model to enable faster fact-based decisions on drug efficacy, optimised control over the trial performance and study finances.
IAG’s cloud platform for robust imaging data management in multi-centre trial setting and central review. One comprehensive software system to control trial progress, conduct central reads and use built-in AI for earlier read-outs and decision support.
Certified: ISO13485, FDA510K, CE, 21 CFR 21-part 11 and has powered 100+ studies, from ph I-IV.
We strategically use of Imaging, such as MRI, CT, PET to accelerates drug development and lower investment risks. Whether you are entering a phase I/II and need early robust efficacy data or preparing a successful H2H or superiority trial, our science, operations and technology teams will work with you to develop the right solution. Find more on what and how we do in in the libraries of successful case histories.
